Y70 (Rabeprazole Sodium Delayed-Release 20 mg)
Pill with imprint Y70 is Yellow, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Aurobindo Pharma Limited.
Rabeprazole is used in the treatment of barrett's esophagus; erosive esophagitis; duodenal ulcer; duodenal ulcer prophylaxis; gerd and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Y70
Rabeprazole Sodium Delayed-Release
- Imprint
- Y70
- Strength
- 20 mg
- Color
- Yellow
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Proton pump inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma Limited
- National Drug Code (NDC)
- 65862-0721
- Inactive Ingredients
-
diacetylated monoglycerides, ethylcellulose (7 mPa.s), ferric oxide yellow, hypromellose phthalate (31% phthalate, 40 cst), magnesium stearate, mannitol, magnesium oxide, magnesium hydroxide, sodium carbonate, magnesium silicate, titanium dioxide, ferrosoferric oxide, shellac
Note: Inactive ingredients may vary.
Related Images for "Y70"
More about rabeprazole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 69 Reviews
- Drug class: proton pump inhibitors
- FDA Alerts (3)
Consumer resources
- Rabeprazole
- Rabeprazole Delayed-Release Tablets
- Rabeprazole Sprinkle Capsules
- Rabeprazole (Advanced Reading)
Other brands: Aciphex, Aciphex Sprinkle
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
